{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:51:56Z","timestamp":1784152316329,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015734","name":"Saint Amanuel Mental Specialized Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.heliyon.2021.e08655","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T21:21:46Z","timestamp":1640121706000},"page":"e08655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Adverse drug reactions among major depressive disorders: patterns by age and gender"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7546-3147","authenticated-orcid":false,"given":"Tariku","family":"Sisay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roza","family":"Wami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2021.e08655_bib1","doi-asserted-by":"crossref","first-page":"5812817","DOI":"10.1155\/2017\/5812817","article-title":"Self-reported adverse drug reactions, medication adherence, and clinical outcomes among major depressive disorder patients in Ethiopia: a prospective hospital based study","volume":"2017","author":"Abegaz","year":"2017","journal-title":"Psychiatr. J."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08655_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0102-311X2004000100021","article-title":"Analysis of medical prescriptions dispensed at health centers in Belo Horizonte, Minas Gerais, Brazil","volume":"20","author":"Acurcio","year":"2004","journal-title":"Cad. Sa\u00fade P\u00fablica"},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08655_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jsps.2013.02.003","article-title":"Factors affecting the development of adverse drug reactions","volume":"22","author":"Alomar","year":"2014","journal-title":"Saudi Pharmaceut. J."},{"issue":"4","key":"10.1016\/j.heliyon.2021.e08655_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40264-015-0387-4","article-title":"Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous reports in VigiBase\u00ae","volume":"39","author":"Ampadu","year":"2016","journal-title":"Drug Saf."},{"issue":"9","key":"10.1016\/j.heliyon.2021.e08655_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","article-title":"Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors","volume":"39","author":"Angamo","year":"2016","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e08655_bib6","first-page":"53","article-title":"First generation antipsychotics: pharmacokinetics, pharmacodynamics, therapeutic effects and side effects: a review","volume":"5","author":"Ayano","year":"2016","journal-title":"RR J. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08655_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1023\/A:1015570104121","article-title":"Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies","volume":"24","author":"Beijer","year":"2002","journal-title":"Pharm. World Sci."},{"issue":"21","key":"10.1016\/j.heliyon.2021.e08655_bib8","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e08655_bib9","first-page":"103","article-title":"The effects of pharmacist interventions on patients with polypharmacy","volume":"4","author":"Chumney","year":"2006","journal-title":"Pharm. Pract."},{"issue":"S42","key":"10.1016\/j.heliyon.2021.e08655_bib10","doi-asserted-by":"crossref","first-page":"s9","DOI":"10.1192\/bjp.179.42.s9","article-title":"Antidepressant use in clinical practice: efficacy v. effectiveness","volume":"179","author":"Donoghue","year":"2001","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.heliyon.2021.e08655_bib11","series-title":"A\u00a0Model for Patient Monitoring in Community Pharmacy","author":"Downs","year":"1993"},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08655_bib12","first-page":"2581","article-title":"Prescription pattern of psychotropic drugs in Shambu General Hospital, Horro Guduru Wollega Zone,Shambu Town, Oromia Regional state, Ethiopia","volume":"1","author":"Dugassa","year":"2018","journal-title":"Int. Res. J. Pharm. Med. Sci. (IRJPMS)"},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08655_bib13","first-page":"168","article-title":"Adverse drug reaction monitoring in Ethiopia: analysis of case reports, 2002-2007","volume":"25","author":"Ermias","year":"2011","journal-title":"Ethiop. J. Health Dev."},{"key":"10.1016\/j.heliyon.2021.e08655_bib14","series-title":"Guidelines for Medicine Registration","year":"2014"},{"key":"10.1016\/j.heliyon.2021.e08655_bib15","series-title":"Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: an Update of the 2007 Comparative Effectiveness Review","author":"Gartlehner","year":"2011"},{"issue":"10","key":"10.1016\/j.heliyon.2021.e08655_bib16","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder third edition","volume":"167","author":"Gelenberg","year":"2010","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08655_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00003727-198208000-00009","article-title":"Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting","volume":"5","author":"Jones","year":"1982","journal-title":"Fam. Community Health"},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08655_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/0976-9668.107289","article-title":"Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: an observational study","volume":"4","author":"Khan","year":"2013","journal-title":"J.\u00a0Nat. Sci. Biol. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08655_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/03602530902722679","article-title":"Pharmacokinetics and drug metabolism in the elderly","volume":"41","author":"Klotz","year":"2009","journal-title":"Drug Metab. Rev."},{"issue":"7-8","key":"10.1016\/j.heliyon.2021.e08655_bib20","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1345\/aph.1L037","article-title":"Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies","volume":"42","author":"Kongkaew","year":"2008","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.heliyon.2021.e08655_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/ijcp.12097","article-title":"The cutaneous adverse drug reactions: risk factors, prognosis and economic impacts","volume":"67","author":"Liao","year":"2013","journal-title":"Int. J. Clin. Pract."},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08655_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/009286150804200501","article-title":"VigiBase, the WHO global ICSR database system: basic facts","volume":"42","author":"Lindquist","year":"2008","journal-title":"Drug Inf. J."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08655_bib23","first-page":"112","article-title":"Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines","volume":"23","author":"Manteuffel","year":"2014","journal-title":"J.\u00a0Wom. Health"},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08655_bib24","first-page":"89","article-title":"Acute, continuation and maintenance phases of antidepressant treatment","volume":"46","author":"Mauri","year":"2005","journal-title":"Minerva Psichiatr."},{"issue":"11","key":"10.1016\/j.heliyon.2021.e08655_bib25","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1210\/me.2009-0242","article-title":"Male-specific hepatic Bcl6: growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5","volume":"23","author":"Meyer","year":"2009","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08655_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227712","article-title":"Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia","volume":"15","author":"Nadew","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2021.e08655_bib27","first-page":"581","article-title":"Female sex as a risk factor for adverse drug reactions","volume":"73","author":"Nakagawa","year":"2015","journal-title":"Nihon rinsho. Jpn J. Clin. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08655_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2021.e08655_bib29","series-title":"Monitoring Adverse Drug Reactions in the Public Health Programs: the Case of the Nigeria TB Program","author":"Nwokike","year":"2008"},{"issue":"3","key":"10.1016\/j.heliyon.2021.e08655_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archinte.163.3.301","article-title":"Depression and adverse drug reactions among hospitalized older adults","volume":"163","author":"Onder","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08655_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40801-015-0054-1","article-title":"Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation","volume":"3","author":"Ozcan","year":"2016","journal-title":"Drugs-real World Outcomes"},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08655_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","article-title":"Extrapyramidal motor side-effects of first-and second-generation antipsychotic drugs","volume":"200","author":"Peluso","year":"2012","journal-title":"Br. J. Psychiatr."},{"issue":"7456","key":"10.1016\/j.heliyon.2021.e08655_bib33","first-page":"15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"5","key":"10.1016\/j.heliyon.2021.e08655_bib34","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M15-2570","article-title":"Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians","volume":"164","author":"Qaseem","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.heliyon.2021.e08655_bib35","first-page":"1085","article-title":"The world health report 2001 \u2014 mental health: new understanding, new hope","volume":"79","author":"Sayers","year":"2001","journal-title":"Bull. World Health Organ."},{"issue":"15","key":"10.1016\/j.heliyon.2021.e08655_bib36","first-page":"251","article-title":"Adverse drug reactions (ADR) and emergencies","volume":"115","author":"Schurig","year":"2018","journal-title":"Dtsch. Arzteblatt Int."},{"issue":"1","key":"10.1016\/j.heliyon.2021.e08655_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0253-7613.75664","article-title":"Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital","volume":"43","author":"Sengupta","year":"2011","journal-title":"Indian J. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2021.e08655_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1542-2011.2010.00050.x","article-title":"Adverse drug reactions in women are health care","volume":"56","author":"Tharpe","year":"2011","journal-title":"J.\u00a0Midwifery Wom. Health"},{"issue":"3","key":"10.1016\/j.heliyon.2021.e08655_bib39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1192\/bjp.bp.108.061960","article-title":"Adverse reactions to antidepressants","volume":"195","author":"Uher","year":"2009","journal-title":"Br. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.heliyon.2021.e08655_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1192\/bjp.185.2.93","article-title":"Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions?","volume":"185","author":"Verdoux","year":"2004","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.heliyon.2021.e08655_bib41","series-title":"Depression","year":"2018"},{"key":"10.1016\/j.heliyon.2021.e08655_bib42","series-title":"WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems","year":"2004"},{"key":"10.1016\/j.heliyon.2021.e08655_bib43","series-title":"WHO-AIMS Report on Mental Health System in Ethiopia","year":"2006"},{"key":"10.1016\/j.heliyon.2021.e08655_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-020-00308-5","article-title":"Sex differences in pharmacokinetics predict adverse drug reactions in women","volume":"11","author":"Zucker","year":"2020","journal-title":"Biol. Sex Differ."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021027584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844021027584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T08:47:49Z","timestamp":1770799669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844021027584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2405844021027584"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08655","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse drug reactions among major depressive disorders: patterns by age and gender","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e08655"}}